More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Nearly 90% of patients who achieved endoscopic response at one year sustained it at two years Omvoh is the first IL-23p19 antagonist to demonstrate…

NEW YORK, Feb. 7, 2025 /PRNewswire/ — Report with the AI impact on market trends – The global music market size is estimated to grow by USD 184.69 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 18.1% during the forecast period. Increasing…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.